PLATELET-ACTIVATING-FACTOR INTERACTION WITH TUMOR-NECROSIS-FACTOR IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

Citation
F. Squadrito et al., PLATELET-ACTIVATING-FACTOR INTERACTION WITH TUMOR-NECROSIS-FACTOR IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY, Journal of lipid mediators, 8(1), 1993, pp. 53-65
Citations number
39
Categorie Soggetti
Biology
Journal title
ISSN journal
09218319
Volume
8
Issue
1
Year of publication
1993
Pages
53 - 65
Database
ISI
SICI code
0921-8319(1993)8:1<53:PIWTIM>2.0.ZU;2-O
Abstract
The role played by platelet-activating factor (PAF) and tumor necrosis factor (TNF-alpha) in myocardial ischaemia-reperfusion injury was inv estigated. Pentobarbital anaesthetized rats were subjected to left mai n coronary artery ligation (1 h) followed by reperfusion (1 h; MI/R). Sham-operated rats were used as controls (Sham MI/R). Myocardial ischa emia-reperfusion injury produced a marked myocardial injury (necrotic area/area-at-risk = 60 +/- 5%; necrotic area/total area = 50 +/- 6%), high serum creatine phosphokinase activity (Sham MI/R = 25 +/- 10 U/ml ; MI/R = 190 +/- 12 U/ml), a severe leukopenia (Sham MI/R = 10 367 +/- 630 WBC X mm3; MI/R = 4123 +/- 120 WBC X MM3) and elevated myocardial myeloperoxidase activity (investigated as an index of leukocyte adhes ion and accumulation) in the area-at-risk (6.2 +/- 0.5 U x 10(-3)/g ti ssue) and in necrotic area (6.6 +/- 0.7 U X 10(-3) /g tissue. Plasma P AF and serum TNF-alpha were significantly increased only during reperf usion. The peak of PAF plasma levels (6.5 +/- 1.2 pmol/ml) occurred ea rlier (15 min of reperfusion) than the peak of serum TNF-alpha (150 U/ ml at 30 min of reperfusion). At the end of reperfusion, macrophage TN F-alpha was also enhanced (Sham MI/R = undectable; MI/R = 148 +/- 12 U /ml). The administration of CV 6209, a specific PAF receptor antagonis t (5 mg/kg, 5 min after occlusion), significantly reduced myocardial i njury (necrotic area/area-at-risk = 27 +/- 3%, P < 0.001; necrotic are a/total area = 10 +/- 2%, P < 0.001), blunted the increase in serum cr eatine phosphokinase (70 +/- 12 U/ml), partially restored leukopenia ( 8234 +/- 143 WBC x mm3) and lowered myeloperoxidase activity in area-a t-risk (2.3 +/- 0.3 U X 10(-3)/g tissue; P < 0.001) and in necrotic ar ea (2.8 +/- 0.5 U X 10(-3)/g tissue). In addition, administration of C V 6209 reduced the serum and macrophage levels of TNF-alpha. The resul ts of this study, therefore, suggest that PAF and TNF-alpha are key me diators of myocardial ischaemia-reperfusion injury and that PAF plays a permissive role in inducing the release of other factor(s) relevant to reperfusion injury.